Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-13

Clinical Trial Update: A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting

View source ↗

Summary

A completed real-world study evaluating tocilizumab for rheumatoid arthritis, with results posted in July 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2017-07-13